Global Botulism Illness Market- Global Industry Analysis and Forecast (2020-2027) – by Treatment Type, Toxin Type, Distribution Channel, and Region.

Global Botulism Illness Market expected to reach around US$ XX Bn by 2027, growing at a CAGR of 6.4% during the forecast period.

Global Botulism Illness Market

To know about the Research Methodology :- Request Free Sample Report

Global Botulism Illness Market Definition:

Botulism is a fatal illness caused by a toxin produced by the bacterium Clostridium botulinum (C. botulinum) and can be life-threatening causing paralyzes. The various symptoms of this disease are weakness, blurred vision, trouble speaking and feeling tired. There are of three main kinds such as food-borne botulism, Wound botulism, Infant botulism. This report emphasizes the botulism illness volume and value at the global level, regional level, and company level. The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.

Global Botulism Illness Market Dynamics:

The report estimates the growth rate of botulism illness market value based on market dynamics, development of inducing factors. The complete information is based on the latest industry news, opportunities, and trends. The growth of the Global Botulism Illness Market is expected to be evolving mainly because of various government initiatives taken by analysis activities on research & development, growing awareness about the disease condition, hygiene factor and accessibility of proper treatment, advancement in new medical technologies, increase in R&D with satisfactory government regulations and the commercial usage of botulinum toxin method over traditional method drive the botulinum toxin market. However, lack of awareness in various underprivileged countries, higher cost of research development & consumption of unhygienic food.

Global botulism illness market, Market Segmentation:

The report covers the brief analytical segments of the botulism illness market thereby providing a wider view at the macro as well as micro levels. By treatment type, antitoxin holds the largest market share of XX% in 2019 and is projected to grow at the highest CAGR of XX.X% to reach US$ XX Mn by 2027. This is because of the adverse use of antitoxins as, it blocks the effects of botulism neurotoxin on the nervous system hence, optimizing the dosage and maintaining the therapeutic efficacy also, strong initiatives taken by the various state governments help to reduce the occurrence and treating the clostridium botulinum infections. Based on anti-toxin, the market is again segmented into trivalent antitoxin and heptavalent botulinum antitoxin. Followed by Meticulous airway management which is also the growing currently to treat respiratory problems commonly in asthmatic attributed to preoperative assessment in Improving the Quality and Safety of Airway Management. Furthermore, Mechanical breathing assistance, Cathartics, Foley catheter treatment requires intensive care to accelerate defecation.

Botulism illness market: Regional analysis

North America’s Botulism illness market was valued at US$ XX million in 2019 and is expected to reach a value of US$ XX million by 2027, with a CAGR of XX% during the forecast period. The major factors which are driving the growth of clostridium botulinum infections market in these regions are increasing demand and growing awareness about various toxic bacteria in market furthermore, Advancement of new techniques and equipment in industries in the botulism illness market globally. Every year, approximately 145 cases of clostridium botulinum infection are reported in the US as estimated by Centers for Disease Control and Prevention (CDC) from which 15% are foodborne, 20% are wound botulism and65% are infant botulism Europe is considered as the second most promising market after North America as they provide proper treatment with suitable diagnoses. Asia Pacific region, New Zealand& Australia are the leading market player for botulism illness as it delivers free medical treatment for infants and variables Middle East & Africa currently is lagging behind but are expected to grow tremendously in the upcoming forecast as it has not been touched.

Global Botulism Illness Market Competitive Analysis

The competitive landscape section in the botulism illness market offers a deep dive into the profiles of the leading companies operating in the global market landscape. It offers captivating insights on the key developments, differential strategies, and other crucial aspects about the key players having a stronghold in the botulism illness market. Allergan, Ipsen, and Merz Pharma are leading and dominating the market by engaging in R&D and discovery, development whereas, Pfizer is one of the world’s largest pharmaceutical companies that develops and produces and manufactures medicines and vaccines for a wide range of medical including infections, and respiratory disorders. The objective of the report is to present a comprehensive analysis of the Global Botulism Illness Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Botulism Illness Market dynamics, structure by analyzing the market segments and projects the Global Botulism Illness Market size. Clear representation of competitive analysis of key players By Treatment type, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Botulism Illness Market make the report investor’s guide

Scope of the Global Botulism Illness Market: Inquire before buying

Global Botulism Illness Market, by Toxin types

• Botulism type A • Botulism type B

Global Botulism Illness Market, by Treatment type

• Antitoxins o Trivalent Antitoxin o Heptavalent botulinium Antitoxin • Meticulous airway management • Cathartics • Foley catheter • Others

Global Botulism Illness Market, By Distribution Channel

• Retail pharmacy • Online stores

Global Botulism Illness Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • Latin America

Global Botulism Illness Market: key Players

• Molecular Targeting Technologies • Microbiotix • XOMA Corporation • AlphaVax • Morphotek • DynPort Vaccine Company LLC • Emergent BioSolutions, In • Cangene Corporation • Morphotek, Inc • Medytox • US WorldMeds • Galderma laboratories • Lanzhou Institute of Biological Products Co., Ltd. • Valeant Pharmaceuticals Inc. (Canada) • ALLERGAN • Ipsen • MerzPharma • Pfizer • Canbex therapeutics ltd • Azidus
Global Botulism Illness Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Botulism Illness Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Botulism Illness Market Analysis and Forecast 6.1. Botulism illness market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Botulism Illness Market Analysis and Forecast, By Toxin types 7.1. Introduction and Definition 7.2. Key Findings 7.3. Botulism illness market Value Share Analysis, By Toxin types 7.4. Botulism illness market Size (US$ Bn) Forecast, By Toxin types 7.5. Botulism illness market Analysis, By Toxin types 7.6. Botulism illness market Attractiveness Analysis, By Toxin types 8. Global Botulism Illness Market Analysis and Forecast, By Treatment type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Botulism illness market Value Share Analysis, By Treatment type 8.4. Botulism illness market Size (US$ Bn) Forecast, By Treatment type 8.5. Botulism illness market Analysis, By Treatment type 8.6. Botulism illness market Attractiveness Analysis, By Treatment type 9. Global Botulism Illness Market Analysis and Forecast, By Distribution Channel 9.1. Introduction and Definition 9.2. Key Findings 9.3. Botulism illness market Value Share Analysis, By Distribution Channel 9.4. Botulism illness market Size (US$ Bn) Forecast, By Distribution Channel 9.5. Botulism illness market Analysis, By Distribution Channel 9.6. Botulism illness market Attractiveness Analysis, By Distribution Channel 10. Global Botulism Illness Market Analysis, by Region 10.1. Botulism illness market Value Share Analysis, by Region 10.2. Botulism illness market Size (US$ Bn) Forecast, by Region 10.3. Botulism illness market Attractiveness Analysis, by Region 11. North America Botulism illness market Analysis 11.1. Key Findings 11.2. North America Botulism illness market Overview 11.3. North America Botulism illness market Value Share Analysis, By Toxin types 11.4. North America Botulism illness market Forecast, By Toxin types 11.4.1. Botulism type A 11.4.2. Botulism type B 11.5. North America Botulism illness market Value Share Analysis, By Treatment type 11.6. North America Botulism illness market Forecast, By Treatment type 11.6.1. Antitoxins 11.6.1.1. Trivalent Antitoxin 11.6.1.2. Heptavalent botulinium Antitoxin 11.6.2. Meticulous airway management 11.6.3. Cathartics 11.6.4. Foley catheter 11.6.5. Others 11.7. North America Botulism illness market Value Share Analysis, By Distribution Channel 11.8. North America Botulism illness market Forecast, By Distribution Channel 11.8.1. Retail pharmacy 11.8.2. Online stores 11.9. North America Botulism illness market Value Share Analysis, by Country 11.10. North America Botulism illness market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Botulism illness market Analysis, by Country 11.12. U.S. Botulism illness market Forecast, By Toxin types 11.12.1. Botulism type A 11.12.2. Botulism type B 11.13. U.S. Botulism illness market Forecast, By Treatment type 11.13.1. Antitoxins 11.13.1.1. Trivalent Antitoxin 11.13.1.2. Heptavalent botulinium Antitoxin 11.13.2. Meticulous airway management 11.13.3. Cathartics 11.13.4. Foley catheter 11.13.5. Others 11.14. U.S. Botulism illness market Forecast, By Distribution Channel 11.14.1. Retail pharmacy 11.14.2. Online stores 11.15. Canada Botulism illness market Forecast, By Toxin types 11.15.1. Botulism type A 11.15.2. Botulism type B 11.16. Canada Botulism illness market Forecast, By Treatment type 11.16.1. Antitoxins 11.16.1.1. Trivalent Antitoxin 11.16.1.2. Heptavalent botulinium Antitoxin 11.16.2. Meticulous airway management 11.16.3. Cathartics 11.16.4. Foley catheter 11.16.5. Others 11.17. Canada Botulism illness market Forecast, By Distribution Channel 11.17.1. Retail pharmacy 11.17.2. Online stores 11.18. North America Botulism illness market Attractiveness Analysis 11.18.1. By Toxin types 11.18.2. By Treatment type 11.18.3. By Distribution Channel 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Botulism illness market Analysis 12.1. Key Findings 12.2. Europe Botulism illness market Overview 12.3. Europe Botulism illness market Value Share Analysis, By Toxin types 12.4. Europe Botulism illness market Forecast, By Toxin types 12.4.1. Botulism type A 12.4.2. Botulism type B 12.5. Europe Botulism illness market Value Share Analysis, By Treatment type 12.6. Europe Botulism illness market Forecast, By Treatment type 12.6.1. Antitoxins 12.6.1.1. Trivalent Antitoxin 12.6.1.2. Heptavalent botulinium Antitoxin 12.6.2. Meticulous airway management 12.6.3. Cathartics 12.6.4. Foley catheter 12.6.5. Others 12.7. Europe Botulism illness market Value Share Analysis, By Distribution Channel 12.8. Europe Botulism illness market Forecast, By Distribution Channel 12.8.1. Retail pharmacy 12.8.2. Online stores 12.9. Europe Botulism illness market Value Share Analysis, by Country 12.10. Europe Botulism illness market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Botulism illness market Analysis, by Country 12.12. Germany Botulism illness market Forecast, By Toxin types 12.12.1. Botulism type A 12.12.2. Botulism type B 12.13. Germany Botulism illness market Forecast, By Treatment type 12.13.1. Antitoxins 12.13.1.1. Trivalent Antitoxin 12.13.1.2. Heptavalent botulinium Antitoxin 12.13.2. Meticulous airway management 12.13.3. Cathartics 12.13.4. Foley catheter 12.13.5. Others 12.14. Germany Botulism illness market Forecast, By Distribution Channel 12.14.1. Retail pharmacy 12.14.2. Online stores 12.15. U.K. Botulism illness market Forecast, By Toxin types 12.15.1. Botulism type A 12.15.2. Botulism type B 12.16. U.K. Botulism illness market Forecast, By Treatment type 12.16.1. Antitoxins 12.16.1.1. Trivalent Antitoxin 12.16.1.2. Heptavalent botulinium Antitoxin 12.16.2. Meticulous airway management 12.16.3. Cathartics 12.16.4. Foley catheter 12.16.5. Others 12.17. U.K. Botulism illness market Forecast, By Distribution Channel 12.17.1. Retail pharmacy 12.17.2. Online stores 12.18. France Botulism illness market Forecast, By Toxin types 12.18.1. Botulism type A 12.18.2. Botulism type B 12.19. France Botulism illness market Forecast, By Treatment type 12.19.1. Antitoxins 12.19.1.1. Trivalent Antitoxin 12.19.1.2. Heptavalent botulinium Antitoxin 12.19.2. Meticulous airway management 12.19.3. Cathartics 12.19.4. Foley catheter 12.19.5. Others 12.20. France Botulism illness market Forecast, By Distribution Channel 12.20.1. Retail pharmacy 12.20.2. Online stores 12.21. Italy Botulism illness market Forecast, By Toxin types 12.21.1. Botulism type A 12.21.2. Botulism type B 12.22. Italy Botulism illness market Forecast, By Treatment type 12.22.1. Antitoxins 12.22.1.1. Trivalent Antitoxin 12.22.1.2. Heptavalent botulinium Antitoxin 12.22.2. Meticulous airway management 12.22.3. Cathartics 12.22.4. Foley catheter 12.22.5. Others 12.23. Italy Botulism illness market Forecast, By Distribution Channel 12.23.1. Retail pharmacy 12.23.2. Online stores 12.24. Spain Botulism illness market Forecast, By Toxin types 12.24.1. Botulism type A 12.24.2. Botulism type B 12.25. Spain Botulism illness market Forecast, By Treatment type 12.25.1. Antitoxins 12.25.1.1. Trivalent Antitoxin 12.25.1.2. Heptavalent botulinium Antitoxin 12.25.2. Meticulous airway management 12.25.3. Cathartics 12.25.4. Foley catheter 12.25.5. Others 12.26. Spain Botulism illness market Forecast, By Distribution Channel 12.26.1. Retail pharmacy 12.26.2. Online stores 12.27. Rest of Europe Botulism illness market Forecast, By Toxin types 12.27.1. Botulism type A 12.27.2. Botulism type B 12.28. Rest of Europe Botulism illness market Forecast, By Treatment type 12.28.1. Antitoxins 12.28.1.1. Trivalent Antitoxin 12.28.1.2. Heptavalent botulinium Antitoxin 12.28.2. Meticulous airway management 12.28.3. Cathartics 12.28.4. Foley catheter 12.28.5. Others 12.29. Rest Of Europe Botulism illness market Forecast, By Distribution Channel 12.29.1. Retail pharmacy 12.29.2. Online stores 12.30. Europe Botulism illness market Attractiveness Analysis 12.30.1. By Toxin types 12.30.2. By Treatment type 12.30.3. By Distribution Channel 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Botulism illness market Analysis 13.1. Key Findings 13.2. Asia Pacific Botulism illness market Overview 13.3. Asia Pacific Botulism illness market Value Share Analysis, By Toxin types 13.4. Asia Pacific Botulism illness market Forecast, By Toxin types 13.4.1. Botulism type A 13.4.2. Botulism type B 13.5. Asia Pacific Botulism illness market Value Share Analysis, By Treatment type 13.6. Asia Pacific Botulism illness market Forecast, By Treatment type 13.6.1. Antitoxins 13.6.1.1. Trivalent Antitoxin 13.6.1.2. Heptavalent botulinium Antitoxin 13.6.2. Meticulous airway management 13.6.3. Cathartics 13.6.4. Foley catheter 13.6.5. Others 13.7. Asia Pacific Botulism illness market Value Share Analysis, By Distribution Channel 13.8. Asia Pacific Botulism illness market Forecast, By Distribution Channel 13.8.1. Retail pharmacy 13.8.2. Online stores 13.9. Asia Pacific Botulism illness market Value Share Analysis, by Country 13.10. Asia Pacific Botulism illness market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Botulism illness market Analysis, by Country 13.12. China Botulism illness market Forecast, By Toxin types 13.12.1. Botulism type A 13.12.2. Botulism type B 13.13. China Botulism illness market Forecast, By Treatment type 13.13.1. Antitoxins 13.13.1.1. Trivalent Antitoxin 13.13.1.2. Heptavalent botulinium Antitoxin 13.13.2. Meticulous airway management 13.13.3. Cathartics 13.13.4. Foley catheter 13.13.5. Others 13.14. China Botulism illness market Forecast, By Distribution Channel 13.14.1. Retail pharmacy 13.14.2. Online stores 13.15. India Botulism illness market Forecast, By Toxin types 13.15.1. Botulism type A 13.15.2. Botulism type B 13.16. India Botulism illness market Forecast, By Treatment type 13.16.1. Antitoxins 13.16.1.1. Trivalent Antitoxin 13.16.1.2. Heptavalent botulinium Antitoxin 13.16.2. Meticulous airway management 13.16.3. Cathartics 13.16.4. Foley catheter 13.16.5. Others 13.17. India Botulism illness market Forecast, By Distribution Channel 13.17.1. Retail pharmacy 13.17.2. Online stores 13.18. Japan Botulism illness market Forecast, By Toxin types 13.18.1. Botulism type A 13.18.2. Botulism type B 13.19. Japan Botulism illness market Forecast, By Treatment type 13.19.1. Antitoxins 13.19.1.1. Trivalent Antitoxin 13.19.1.2. Heptavalent botulinium Antitoxin 13.19.2. Meticulous airway management 13.19.3. Cathartics 13.19.4. Foley catheter 13.19.5. Others 13.20. Japan Botulism illness market Forecast, By Distribution Channel 13.20.1. Retail pharmacy 13.20.2. Online stores 13.21. ASEAN Botulism illness market Forecast, By Toxin types 13.21.1. Botulism type A 13.21.2. Botulism type B 13.22. ASEAN Botulism illness market Forecast, By Treatment type 13.22.1. Antitoxins 13.22.1.1. Trivalent Antitoxin 13.22.1.2. Heptavalent botulinium Antitoxin 13.22.2. Meticulous airway management 13.22.3. Cathartics 13.22.4. Foley catheter 13.22.5. Others 13.23. ASEAN Botulism illness market Forecast, By Distribution Channel 13.23.1. Retail pharmacy 13.23.2. Online stores 13.24. Rest of Asia Pacific Botulism illness market Forecast, By Toxin types 13.24.1. Botulism type A 13.24.2. Botulism type B 13.25. Rest of Asia Pacific Botulism illness market Forecast, By Treatment type 13.25.1. Antitoxins 13.25.1.1. Trivalent Antitoxin 13.25.1.2. Heptavalent botulinium Antitoxin 13.25.2. Meticulous airway management 13.25.3. Cathartics 13.25.4. Foley catheter 13.25.5. Others 13.26. Rest of Asia Pacific Botulism illness market Forecast, By Distribution Channel 13.26.1. Retail pharmacy 13.26.2. Online stores 13.27. Asia Pacific Botulism illness market Attractiveness Analysis 13.27.1. By Toxin types 13.27.2. By Treatment type 13.27.3. By Distribution Channel 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Botulism illness market Analysis 14.1. Key Findings 14.2. Middle East & Africa Botulism illness market Overview 14.3. Middle East & Africa Botulism illness market Value Share Analysis, By Toxin types 14.4. Middle East & Africa Botulism illness market Forecast, By Toxin types 14.4.1. Botulism type A 14.4.2. Botulism type B 14.5. Middle East & Africa Botulism illness market Value Share Analysis, By Treatment type 14.6. Middle East & Africa Botulism illness market Forecast, By Treatment type 14.6.1. Antitoxins 14.6.1.1. Trivalent Antitoxin 14.6.1.2. Heptavalent botulinium Antitoxin 14.6.2. Meticulous airway management 14.6.3. Cathartics 14.6.4. Foley catheter 14.6.5. Others 14.7. Middle East & Africa Botulism illness market Value Share Analysis, By Distribution Channel 14.8. Middle East & Africa Botulism illness market Forecast, By Distribution Channel 14.8.1. Retail pharmacy 14.8.2. Online stores 14.9. Middle East & Africa Botulism illness market Value Share Analysis, by Country 14.10. Middle East & Africa Botulism illness market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Botulism illness market Analysis, by Country 14.12. GCC Botulism illness market Forecast, By Toxin types 14.12.1. Botulism type A 14.12.2. Botulism type B 14.13. GCC Botulism illness market Forecast, By Treatment type 14.13.1. Antitoxins 14.13.1.1. Trivalent Antitoxin 14.13.1.2. Heptavalent botulinium Antitoxin 14.13.2. Meticulous airway management 14.13.3. Cathartics 14.13.4. Foley catheter 14.13.5. Others 14.14. GCC Botulism illness market Forecast, By Distribution Channel 14.14.1. Retail pharmacy 14.14.2. Online stores 14.15. South Africa Botulism illness market Forecast, By Toxin types 14.15.1. Botulism type A 14.15.2. Botulism type B 14.16. South Africa Botulism illness market Forecast, By Treatment type 14.16.1. Antitoxins 14.16.1.1. Trivalent Antitoxin 14.16.1.2. Heptavalent botulinium Antitoxin 14.16.2. Meticulous airway management 14.16.3. Cathartics 14.16.4. Foley catheter 14.16.5. Others 14.17. South Africa Botulism illness market Forecast, By Distribution Channel 14.17.1. Retail pharmacy 14.17.2. Online stores 14.18. Rest of Middle East & Africa Botulism illness market Forecast, By Toxin types 14.18.1. Botulism type A 14.18.2. Botulism type B 14.19. Rest of Middle East & Africa Botulism illness market Forecast, By Treatment type 14.19.1. Antitoxins 14.19.1.1. Trivalent Antitoxin 14.19.1.2. Heptavalent botulinium Antitoxin 14.19.2. Meticulous airway management 14.19.3. Cathartics 14.19.4. Foley catheter 14.19.5. Others 14.20. Middle East & Africa Botulism illness market Forecast, By Distribution Channel 14.20.1. Retail pharmacy 14.20.2. Online stores 14.21. Middle East & Africa Botulism illness market Attractiveness Analysis 14.21.1. By Toxin types 14.21.2. By Treatment type 14.21.3. By Distribution Channel 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Botulism illness market Analysis 15.1. Key Findings 15.2. South America Botulism illness market Overview 15.3. South America Botulism illness market Value Share Analysis, By Toxin types 15.4. South America Botulism illness market Forecast, By Toxin types 15.4.1. Botulism type A 15.4.2. Botulism type B 15.5. South America Botulism illness market Value Share Analysis, By Treatment type 15.6. South America Botulism illness market Forecast, By Treatment type 15.6.1. Antitoxins 15.6.1.1. Trivalent Antitoxin 15.6.1.2. Heptavalent botulinium Antitoxin 15.6.2. Meticulous airway management 15.6.3. Cathartics 15.6.4. Foley catheter 15.6.5. Others 15.7. South America Botulism illness market Value Share Analysis, By Distribution Channel 15.8. South America Botulism illness market Forecast, By Distribution Channel 15.8.1. Retail pharmacy 15.8.2. Online stores 15.9. South America Botulism illness market Value Share Analysis, by Country 15.10. South America Botulism illness market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Botulism illness market Analysis, by Country 15.12. Brazil Botulism illness market Forecast, By Toxin types 15.12.1. Botulism type A 15.12.2. Botulism type B 15.13. Brazil Botulism illness market Forecast, By Treatment type 15.13.1. Antitoxins 15.13.1.1. Trivalent Antitoxin 15.13.1.2. Heptavalent botulinium Antitoxin 15.13.2. Meticulous airway management 15.13.3. Cathartics 15.13.4. Foley catheter 15.13.5. Others 15.14. Brazil Botulism illness market Forecast, By Distribution Channel 15.14.1. Retail pharmacy 15.14.2. Online stores 15.15. Mexico Botulism illness market Forecast, By Toxin types 15.15.1. Botulism type A 15.15.2. Botulism type B 15.16. Mexico Botulism illness market Forecast, By Treatment type 15.16.1. Antitoxins 15.16.1.1. Trivalent Antitoxin 15.16.1.2. Heptavalent botulinium Antitoxin 15.16.2. Meticulous airway management 15.16.3. Cathartics 15.16.4. Foley catheter 15.16.5. Others 15.17. Mexico Botulism illness market Forecast, By Distribution Channel 15.17.1. Retail pharmacy 15.17.2. Online stores 15.18. Rest of South America Botulism illness market Forecast, By Toxin types 15.18.1. Botulism type A 15.18.2. Botulism type B 15.19. Rest of South America Botulism illness market Forecast, By Treatment type 15.19.1. Antitoxins 15.19.1.1. Trivalent Antitoxin 15.19.1.2. Heptavalent botulinium Antitoxin 15.19.2. Meticulous airway management 15.19.3. Cathartics 15.19.4. Foley catheter 15.19.5. Others 15.20. Others Rest of South America Botulism illness market Forecast, By Distribution Channel 15.20.1. Retail pharmacy 15.20.2. Online stores 15.21. South America Botulism illness market Attractiveness Analysis 15.21.1. By Toxin types 15.21.2. By Treatment type 15.21.3. By Distribution Channel 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward 16.2.3.3. Integration 16.3. Company Profiles: Key Players 16.3.1. Molecular Targeting Technologies 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Microbiotix 16.3.3. XOMA Corporation 16.3.4. AlphaVax 16.3.5. Morphotek 16.3.6. DynPort Vaccine Company LLC 16.3.7. Emergent BioSolutions, In 16.3.8. Cangene Corporation 16.3.9. Morphotek, Inc 16.3.10. Medytox 16.3.11. US WorldMeds 16.3.12. Galderma laboratories 16.3.13. Lanzhou Institute of Biological Products Co., Ltd. 16.3.14. Valeant Pharmaceuticals Inc. (Canada) 16.3.15. ALLERGAN 16.3.16. Ipsen 16.3.17. MerzPharma 16.3.18. Pfizer 16.3.19. Canbex therapeutics ltd 16.3.20. Azidus 17. Primary Key Insights

About This Report

Report ID54023
Category Healthcare
Published DateFeb 2020
Updated Date
Contact Us